DE
AMGN icon

Defiance ETFs’s Amgen AMGN Stock Holding History

Defiance ETFs’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825K Buy
2,282
+494
+28% +$169K 0.01% 247
2026
Q1 		$629K Buy
+1,788
New +$637K 0.01% 251

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Defiance ETFs's AMGN Position: Q2 2026 in Review

Defiance ETFs increased its Amgen (AMGN) stake by 28% in Q2 2026, buying an estimated $169K and bringing the position to 2,282 shares worth $825K. The position accounts for 0.01% of the portfolio, ranked #247.

Defiance ETFs first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Defiance ETFs held 2,282 shares of Amgen worth $825K as of Q2 2026.
  • Defiance ETFs bought 494 Amgen shares in Q2 2026, an estimated $169K.
  • Amgen made up 0.01% of Defiance ETFs's portfolio in Q2 2026, its #247 holding.
  • Defiance ETFs first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.